Westbrook, Maine, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, reported results for the quarter ended September 30, 2017.
Quarter 3 2017 and Recent Highlights:
- Secured $10 million of funding from Knight Therapeutics (Barbados) Inc. with the potential to increase to $30 million
- Launched The Queen Pegasus, a lash elixir kit sold using The Synergy Effect
- Hired Robin Mendenhall as Head of Sales – Beauty
- Hired Jeffrey Kadanoff as Chief Financial Officer
- Hired Patrick McCullough as President
- Appointed Gale Bensussen as an independent Board Member
- Finalized implementation of new systems which will facilitate exponential growth
Net sales for the third quarter were $9.2 million, compared to $11.5 million for the same quarter in 2016, a 20% decrease. For the third quarter, our net income was $0.01 million or $0.00 (basic and diluted) earnings per share, compared to net income of $3 million or $0.04 (basic and diluted) earnings per share for 2016.
Net sales for the nine months ended September 30, 2017 were $29.3 million, compared to $28 million for the same period in 2016, a 4.6% increase. For the nine months ended September 30, 2017, net income was $2.6 million, or $0.03 (basic and diluted) earnings per share, compared to net income of $5.8 million or $0.07 (basic and diluted) earnings per share for the same period in 2016.
We currently focus on Adjusted EBITDA to evaluate our business relationships and our resulting operating performance and financial position. Adjusted EBITDA for the quarter was $1.3 million and for the nine months ended September 30, 2017 it was $5.7 million.
EBITDA and Adjusted EBITDA are considered non-GAAP financial measures. The Company’s definitions of EBITDA and adjusted EBITDA might not be comparable to similarly titled measures reported by other companies.
“The past few months were highlighted by Synergy solidifying its executive team, systems and finances to enable sustained growth in the years to come,” said Jack Ross, CEO of Synergy. “More over with the launch of The Queen Pegasus, this marks the third straight quarter, following Per-fékt Beauty and Sneaky Vaunt, that Synergy added a new brand to its expanding portfolio of products.”
About Synergy CHC Corp.
Synergy CHC Corp. is a consumer health care & beauty company that is in the process of building a portfolio of best-in-class consumer product brands. Synergy’s strategy is to grow its portfolio both organically and by further acquisition. Synergy’s diversified portfolio now includes FOCUSFactor™, Flat Tummy Tea™, Per-fékt Beauty™, Sneaky Vaunt™, The Queen Pegasus™, Neuragen™, and Hand MD™. For more information, please visit www.synergychc.com.
Flat Tummy Tea®
Flat Tummy Tea’s uniquely formulated two-step herbal detox tea works to naturally help speed metabolism, boost energy and reduce bloating to flatten your tummy. It is currently sold exclusively online to a global, 20-30 year old female, predominantly American market.
Since being founded in 2013, Flat Tummy Tea has grown rapidly, largely attributed to the strength of their branding and their innovative and effective use of social media. Their secret is a very specific process and ROI based algorithm used on various online platforms. To date, Flat Tummy Tea has built a targeted social media following of over 1,400,000, many of whom are now customers.
Flat Tummy Tea now has over 13,000 positive written reviews on their website, www.flattummyco.com or visit their Instagram page.
FOCUSfactor is sold at America’s leading retailers such as Costco, Sam’s Club, Wal-Mart, BJ’s Walgreens, CVS and The Vitamin Shoppe. FOCUSfactor, America’s leading brain health supplement, is a nutritional supplement that includes a proprietary blend of brain supporting vitamins, minerals, antioxidants and other nutrients. In December 2012, the United States Patent and Trademark Office issued US Patent 8,329,227 covering FOCUSfactor’s proprietary formulation “for enhanced mental function.” The issuance of the patent marked one of the few times a patent has been issued for a nationally branded nutritional supplement. FOCUSfactor is clinically tested with results demonstrating improvements in focus, concentration and memory in healthy adults. www.focusfactor.com
Per-fékt Beauty is one of Synergy's newest brands that was acquired in June of 2017. Per-fékt Beauty markets and sells a specialized range of beauty products (makeup, skin-care & body) via retailers and online through social media channels.
Per-fékt Beauty is well established in the beauty retail space (Sephora and Ulta), opening up an exciting retail opportunity for the rest of our products in that industry. Even more exciting is the potential to apply the same ROI based algorithm that Flat Tummy Tea uses and is currently being used by The Synergy Effect on various online marketing platforms – what could be more per-fekt?
Per-fékt Beauty be found at perfektbeauty.com or visit their Instagram page.
Sneaky Vaunt is one of Synergy's newest brands that just launched in March of 2017. Sneaky Vaunt markets and sells a backless, strapless, stick on, push up bra exclusively online through social media channels.
Sneaky Vaunt is being marketed on the same ROI based algorithm that Flat Tummy Tea uses and is currently being used by The Synergy Effect on various online marketing platforms. In just over six months, Sneaky Vaunt has built a targeted social media following of over 400,000 on Instagram.
Sneaky Vaunt can be found at sneakyvaunt.com or visit their Instagram page.
The Queen Pegasus®
The Queen Pegasus is Synergy's newest brand that just launched in August of 2017. The Queen Pegasus markets and sells a lash elixir kit exclusively online through social media channels.
The Queen Pegasus is being marketed on the same ROI based algorithm that Flat Tummy Tea and Sneaky Vaunt use and is currently being used by The Synergy Effect on various online marketing platforms.
The Queen Pegasus can be found at thequeenpegasus.com or visit their Instagram page.
Neuragen® is a topical product that works directly at the site of the pain as opposed to oral products. Neuragen® reduces the spontaneous firing of damaged peripheral nerves. By calming these firings at the source, Neuragen® is clinically shown to reduce shooting and burning pains quickly and without the side effects of orally taken medications. This is in part due to the small lipophilic molecules found in Neuragen® which rapidly carry the active ingredients through the rough outer layer of the skin to the site of the pain. Neuragen® is available over the counter in most local pharmacies either in the diabetic section or the analgesic (pain) section. For more information, please visit www.neuragen.com.
Hand MD is the world’s first anti-aging skincare line formulated specifically for the hands. Hands reveal a woman’s true age and the rejuvenation of the hand has become women’s #1 aging concern. Developed by Kara Harshbarger and renowned celebrity dermatologist Dr. Alex Khadavi, Hand MD’s extensive clinical trials show significant improvement in the appearance of fine lines and wrinkles, skin hydration, hyper-pigmentation and radiance. HAND MD launched on QVC and sold out in an astonishing 5 minutes. www.hand-md.com.
The Synergy Effect®
The Synergy Effect is Synergy’s fast-growth online marketing platform, a growth engine built to grow brands exponentially online. Launched in 2017, The Synergy Effect powers Synergy’s brands online, driving revenue using best-in-class digital strategy and its proprietary ROI algorithm. Already boasting success stories including Flat Tummy Tea and Sneaky Vaunt, both of which have experienced unprecedented growth in digital and social media, The Synergy Effect will spend the upcoming year further unlocking the huge online growth potential within Synergy’s existing portfolio of brands, as well as brands acquired by Synergy.
More information on The Synergy Effect can be found at www.thesynergyeffect.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management’s expectations, beliefs, goals, plans or Synergy’s prospects should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including: Synergy’s ability to integrate any new products into its current operations; the risks and uncertainties associated with Synergy’s ability to manage its cash resources; obtaining additional financing to support Synergy’s operations; Synergy’s dependence on third parties for its research and development, manufacturing and distribution functions; Synergy’s dependence on its license relationships; protecting the intellectual property developed by or licensed to Synergy; and Synergy’s ability to build its operations to support its business strategy and promote its products. These and other risks are described in greater detail in Synergy’s filings with the SEC, copies of which are available free of charge at the SEC’s website (www.sec.gov) or upon request from Synergy. Synergy may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. Synergy assumes no obligation and does not intend to update these forward-looking statements, except as required by law.
Contact: Jack Ross, Chairman / CEO Synergy CHC Corp Jack@synergychc.com 615-939-9004